 |
Icon Bioscience, Inc. will pursue corporate partnerships and out-licensing agreements of its Verisome® technology in limited opportunistic circumstances. IBI is currently involved with multiple collaborations involving a wide variety of new chemical entities targeting various ophthalmic indications. These collaborations involve small molecules and biologics
